Which is better, PEN or UTHR?

On the Buffett-Fit framework, United Therapeutics Corporation (UTHR) currently grades higher than PEN — 71/100 (B grade) vs 57/100 (C). That said, "better" depends on which framework you trust — PEN wins on Philip Fisher and Joel Greenblatt; UTHR wins on Warren Buffett, Benjamin Graham, Peter Lynch, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy PEN or UTHR?

This page is an educational comparison, not investment advice. Both PEN and UTHR are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is PEN better than UTHR for value investing?

On the Buffett-style value-investing framework, UTHR currently grades higher — 71/100 vs 57/100, a 14-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between PEN and UTHR on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). PEN currently scores 57/100 (C grade); UTHR scores 71/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, PEN or UTHR?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. PEN and UTHR are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, PEN or UTHR?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are PEN and UTHR both Healthcare stocks?

Yes — both Penumbra, Inc. (PEN) and United Therapeutics Corporation (UTHR) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this PEN vs UTHR comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Penumbra

United Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

PEN

Penumbra

Market cap

$12.93B

Sector

Healthcare

UTHR

United Therapeutics

Market cap

$24.13B

Sector

Healthcare

Overall winner

United Therapeutics UTHR

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	PEN	UTHR	Winner
Warren Buffett	57C	71B	UTHR
Benjamin Graham	72D	76B	UTHR
Philip Fisher	78C	76B	PEN
Peter Lynch	54C	62C	UTHR
Joel Greenblatt	52D	46D	PEN
Charlie Munger	51D	64C	UTHR
Terry Smith	54D	64C	UTHR

Side-by-side metrics

Metric	PEN	UTHR
Market cap	$12.93B	$24.13B
P/E (TTM)	74.0x	19.2x
EV/EBIT	66.9x	15.2x
ROIC (TTM)	9.26%	18.81%
Gross margin	67.38%	86.58%
Net margin	11.76%	40.61%
Revenue CAGR 5y	17.06%	17.22%
EPS CAGR 5y	139.03%	29.84%
Debt / Equity	0.1x	-
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

PEN leads on

EPS CAGR 5y139.03%vs 29.84%+79%

UTHR leads on

Debt / Equity-vs 0.1x+100%
EV/EBIT15.2xvs 66.9x+77%
P/E (TTM)19.2xvs 74.0x+74%
Net margin40.61%vs 11.76%+71%

More like PEN

PEN vs HALO PEN vs LMAT PEN vs RMD PEN vs LLY PEN vs HAE PEN vs IDXX

More like UTHR

UTHR vs HALO UTHR vs LMAT UTHR vs RMD UTHR vs LLY UTHR vs HAE UTHR vs IDXX

Read the full Buffett-Brain analysis for PEN Read the full Buffett-Brain analysis for UTHR

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

Penumbra

United Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

PEN

Penumbra

Market cap

$12.93B

Sector

Healthcare

UTHR

United Therapeutics

Market cap

$24.13B

Sector

Healthcare

Overall winner

United Therapeutics UTHR

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	PEN	UTHR	Winner
Warren Buffett	57C	71B	UTHR
Benjamin Graham	72D	76B	UTHR
Philip Fisher	78C	76B	PEN
Peter Lynch	54C	62C	UTHR
Joel Greenblatt	52D	46D	PEN
Charlie Munger	51D	64C	UTHR
Terry Smith	54D	64C	UTHR

Side-by-side metrics

Metric	PEN	UTHR
Market cap	$12.93B	$24.13B
P/E (TTM)	74.0x	19.2x
EV/EBIT	66.9x	15.2x
ROIC (TTM)	9.26%	18.81%
Gross margin	67.38%	86.58%
Net margin	11.76%	40.61%
Revenue CAGR 5y	17.06%	17.22%
EPS CAGR 5y	139.03%	29.84%
Debt / Equity	0.1x	-
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

PEN leads on

EPS CAGR 5y139.03%vs 29.84%+79%

UTHR leads on

Debt / Equity-vs 0.1x+100%
EV/EBIT15.2xvs 66.9x+77%
P/E (TTM)19.2xvs 74.0x+74%
Net margin40.61%vs 11.76%+71%

More like PEN

PEN vs HALO PEN vs LMAT PEN vs RMD PEN vs LLY PEN vs HAE PEN vs IDXX

More like UTHR

UTHR vs HALO UTHR vs LMAT UTHR vs RMD UTHR vs LLY UTHR vs HAE UTHR vs IDXX

Read the full Buffett-Brain analysis for PEN Read the full Buffett-Brain analysis for UTHR

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.